Canada's home healthcare market is expanding at the market size of about $29 Bn in 2022 with a CAGR of 7.93% and is forecasted to grow up to $53 Bn in the year 2030 due to the aging population and the associated increase in disease rates. The Canada home healthcare market analysis is segmented by device type, service type, and by indication type. Johnson and Johnson, Omron Healthcare, and 3M Healthcare are the major players in the home healthcare market.
Canada's home healthcare market size is at around $29 Bn in 2022 and is projected to reach $53 Bn in 2030, exhibiting a CAGR of 7.93% during the forecast period. By 2022, total health expenditures in Canada were anticipated to exceed $331 Bn. According to Canadian Institute for Health Information (CIHI), total health spending in Canada amounted to about $8,653 per person in 2022, down from a peak of 13.8% in 2020. This represents 12.2% of the country's Gross Domestic Product (GDP). The public sector, which supports healthcare services, and the private sector, which provides these services, make up Canada's hybrid public-private healthcare system.
Home healthcare services in Canada support a person who is aging and requires assistance to live independently, is managing chronic medical conditions, is recuperating from a medical setback, or has special requirements or a disability. Home healthcare services are not covered by the Canada Health Act's public insurance program in the same way that hospital and physician services are. In Canada, provincial, territorial, and some municipal governments provide the majority of home and community care services. Transfer funds for social and health services are funded by the federal government.
Market Growth Drivers
The market for home healthcare in Canada is primarily driven by rising rates of chronic diseases and an aging population. The frequency of chronic illnesses and injuries among the older population in Canada increases the demand for home healthcare services to keep a close eye on and take care of their health.
Market Restraints
Home healthcare services in Canada are funded by a combination of private and public sources. However, the lack of sufficient funding from the government can be a major restraint to the growth of the home healthcare market in Canada. In some rural and remote areas in Canada, access to home healthcare services may be limited due to a shortage of healthcare professionals and infrastructure. This can act as a restraint to the growth of the home healthcare market in these areas. Regulatory issues related to the provision of home healthcare services in Canada, act as a restraint on the growth of the market.
Key Players
In order for provinces and territories to be eligible for full federal cash transfers to promote health, the Canada Health Act outlines requirements and conditions for health insurance plans. Provinces and territories are expected to offer appropriate access to hospital and doctor services that are required for medical reasons. The vast majority of home healthcare services are provided by provincial, territory, and local governments. Transfer payments for social and health services are a source of financial support from the federal government.
In Canada, the federal, provincial, and private sectors all have responsibility for overseeing the compensation of pharmaceuticals, biologicals, and medical devices. A new Reimbursement Policy under the Canada Health Act is being implemented by the federal government. In accordance with this new regulation, the federal Minister of Health may decide to repay a province or territory that is subject to a deduction if it complies with the Act by the end of the fiscal year.
1. Executive Summary
1.1 Service Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Healthcare Services Market in Country
1.6 Recent Developments in the Country
2. Market Size and Forecasting
2.1 Market Size (With Excel and Methodology)
2.2 Market Segmentation (Check all Segments in Segmentation Section)
3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints
4. Competitive Landscape
4.1 Major Market Share
4.2 Key Company Profile (Check all Companies in the Summary Section)
4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)
5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Services
5.3 Reimbursement Process for Treatment
6. Methodology and Scope
By Device Type (Revenue, USD Billion):
Based on the device type the market is segmented into testing, screening, monitoring devices, therapeutic home healthcare devices, and mobility assist.
By Service Type (Revenue, USD Billion):
By Indication Type (Revenue, USD Billion):
Methodology for Database Creation
Our database offers a comprehensive list of healthcare centers, meticulously curated to provide detailed information on a wide range of specialties and services. It includes top-tier hospitals, clinics, and diagnostic facilities across 30 countries and 24 specialties, ensuring users can find the healthcare services they need.
Additionally, we provide a comprehensive list of Key Opinion Leaders (KOLs) based on your requirements. Our curated list captures various crucial aspects of the KOLs, offering more than just general information. Whether you're looking to boost brand awareness, drive engagement, or launch a new product, our extensive list of KOLs ensures you have the right experts by your side. Covering 30 countries and 36 specialties, our database guarantees access to the best KOLs in the healthcare industry, supporting strategic decisions and enhancing your initiatives.
How Do We Get It?
Our database is created and maintained through a combination of secondary and primary research methodologies.
1. Secondary Research
With many years of experience in the healthcare field, we have our own rich proprietary data from various past projects. This historical data serves as the foundation for our database. Our continuous process of gathering data involves:
With extensive experience in the field, we have developed a proprietary GenAI-based technology that is uniquely tailored to our organization. This advanced technology enables us to scan a wide array of relevant information sources across the internet. Our data-gathering process includes:
2. Primary Research
To complement and validate our secondary data, we engage in primary research through local tie-ups and partnerships. This process involves:
Combining Secondary and Primary Research
By integrating both secondary and primary research methodologies, we ensure that our database is comprehensive, accurate, and up-to-date. The combined process involves:
Through this meticulous process, we create a final database tailored to each region and domain within the healthcare industry. This approach ensures that our clients receive reliable and relevant data, empowering them to make informed decisions and drive innovation in their respective fields.
We value your inquiry and offer free customization with every report to fulfil your exact research needs.